Rare diseases
Investigational molecules
Locations
Back to Germany1 191 clinical trials in Munich, Germany across 8 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in GermanyKlinischeStudien.de(opens in a new tab)Study of TOL2 safety and immune response in patients with generalized myasthenia gravis
GermanyGermanySafety and early effectiveness study of VG801 subretinal injection in patients with ABCA4 mutation-associated retinal dystrophy
GermanyStudy of Nebulized Human Normal Immunoglobulin (CSL787) for Adults with Non-cystic Fibrosis Bronchiectasis to Find Best Dose and Test Safety
GermanyStudy of Empagliflozin to Improve Heart Function in Adults with Pulmonary Arterial Hypertension
GermanySafety and Effectiveness of Intravenous Sonazoid for Contrast-Enhanced Liver Ultrasound in Children with Focal Liver Lesions
GermanyStudy on Efgartigimod for Patients with Autoimmune Dementia
GermanyStudy on the Effectiveness and Safety of Masitinib and Riluzole for Patients with Amyotrophic Lateral Sclerosis (ALS)
GermanyStudy on the Safety and Effectiveness of Metal Panel Allergens for Diagnosing Allergic Contact Dermatitis and Eczema in Patients
GermanyStudy on Thiethylperazine and Florbetaben (18F) for Early Alzheimer's Disease Patients
GermanyStudy of Loncastuximab Tesirine and Epcoritamab for Patients with Relapsed or Refractory Diffuse Large B-cell Lymphoma, High-grade B-cell Lymphoma, or Follicular Lymphoma Grade 3B
GermanyStudy on the Safety and Effectiveness of Trastuzumab Deruxtecan with Drug Combination for Patients with HER2+ Resectable Esophagogastric Cancer
GermanyThe busiest research cities in the country
What the registry says about research in the country
Groundbreaking studies focusing on various cancer types, including metastatic prostate cancer, colorectal cancer, and bladder cancer. Novel therapeutic approaches combining immunotherapy with established treatments are being investigated.
Research aims to improve survival rates and treatment effectiveness through targeted therapies and immunological approaches.
Important research in heart disease and blood conditions, including studies on TTR amyloidosis and prevention of thrombotic events. Novel medications are being tested to improve patient outcomes.
Focus on developing innovative treatments for complex cardiovascular conditions and preventing blood clots.
Advanced research into neurological conditions, particularly focusing on Alzheimer's disease and autoimmune dementia. Studies aim to develop new therapeutic approaches and improve diagnostic tools.
Innovative approaches to treating and managing neurodegenerative conditions.
Critical research in HIV prevention and immune system modulation, including studies on transplant medicine and vaccine development for yellow fever.
Focus on preventing infectious diseases and improving transplant outcomes through immunological interventions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
